T. Rowe Price Associates’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $51.8M | Sell |
936,703
-385,303
| -29% | -$21.3M | 0.01% | 725 |
|
|
2025
Q1 | $63.9M | Sell |
1,322,006
-70,646
| -5% | -$3.42M | 0.01% | 646 |
|
|
2024
Q4 | $53.8M | Buy |
1,392,652
+83,185
| +6% | +$3.21M | 0.01% | 728 |
|
|
2024
Q3 | $58.9M | Buy |
1,309,467
+99,925
| +8% | +$4.5M | 0.01% | 709 |
|
|
2024
Q2 | $41.9M | Buy |
1,209,542
+390,246
| +48% | +$13.5M | 0.01% | 775 |
|
|
2024
Q1 | $23.7M | Sell |
819,296
-4,444
| -0.5% | -$129K | ﹤0.01% | 937 |
|
|
2023
Q4 | $18.9M | Sell |
823,740
-8,253
| -1% | -$189K | ﹤0.01% | 971 |
|
|
2023
Q3 | $13.9M | Buy |
831,993
+300
| +0% | +$5K | ﹤0.01% | 999 |
|
|
2023
Q2 | $23M | Buy |
831,693
+416,419
| +100% | +$11.5M | ﹤0.01% | 900 |
|
|
2023
Q1 | $9.55M | Buy |
+415,274
| New | +$9.55M | ﹤0.01% | 1063 |
|
|
2022
Q2 | – | Sell |
-300,468
| Closed | -$7.12M | – | 2995 |
|
|
2022
Q1 | $7.12M | Sell |
300,468
-76,664
| -20% | -$1.82M | ﹤0.01% | 1414 |
|
|
2021
Q4 | $12.9M | Sell |
377,132
-114,509
| -23% | -$3.92M | ﹤0.01% | 1369 |
|
|
2021
Q3 | $8.71M | Sell |
491,641
-494,613
| -50% | -$8.76M | ﹤0.01% | 1433 |
|
|
2021
Q2 | $44.3M | Buy |
986,254
+72,664
| +8% | +$3.26M | ﹤0.01% | 1069 |
|
|
2021
Q1 | $23.7M | Buy |
913,590
+68,195
| +8% | +$1.77M | ﹤0.01% | 1234 |
|
|
2020
Q4 | $17M | Buy |
845,395
+259,536
| +44% | +$5.23M | ﹤0.01% | 1252 |
|
|
2020
Q3 | $11.5M | Sell |
585,859
-161,775
| -22% | -$3.16M | ﹤0.01% | 1265 |
|
|
2020
Q2 | $13.2M | Buy |
747,634
+705,018
| +1,654% | +$12.5M | ﹤0.01% | 1241 |
|
|
2020
Q1 | $301K | Buy |
42,616
+100
| +0.2% | +$706 | ﹤0.01% | 2186 |
|
|
2019
Q4 | $300K | Buy |
42,516
+15,151
| +55% | +$107K | ﹤0.01% | 2310 |
|
|
2019
Q3 | $329K | Buy |
27,365
+7,879
| +40% | +$94.7K | ﹤0.01% | 2244 |
|
|
2019
Q2 | $236K | Buy |
19,486
+7,586
| +64% | +$91.9K | ﹤0.01% | 2361 |
|
|
2019
Q1 | $150K | Sell |
11,900
-9,200
| -44% | -$116K | ﹤0.01% | 2434 |
|
|
2018
Q4 | $142K | Buy |
21,100
+4,600
| +28% | +$31K | ﹤0.01% | 2444 |
|
|
2018
Q3 | $170K | Hold |
16,500
| – | – | ﹤0.01% | 2472 |
|
|
2018
Q2 | $111K | Sell |
16,500
-43
| -0.3% | -$289 | ﹤0.01% | 2507 |
|
|
2018
Q1 | $142K | Buy |
16,543
+6,722
| +68% | +$57.7K | ﹤0.01% | 2446 |
|
|
2017
Q4 | $204K | Buy |
+9,821
| New | +$204K | ﹤0.01% | 2400 |
|